AU2002309873B2 - Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer - Google Patents

Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer Download PDF

Info

Publication number
AU2002309873B2
AU2002309873B2 AU2002309873A AU2002309873A AU2002309873B2 AU 2002309873 B2 AU2002309873 B2 AU 2002309873B2 AU 2002309873 A AU2002309873 A AU 2002309873A AU 2002309873 A AU2002309873 A AU 2002309873A AU 2002309873 B2 AU2002309873 B2 AU 2002309873B2
Authority
AU
Australia
Prior art keywords
protein
cells
cancer
amino acid
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002309873A
Other languages
English (en)
Other versions
AU2002309873A1 (en
Inventor
Pia M. Challita-Eid
Mary Faris
Wangmao Ge
Aya Jakobovits
Robert Kendall Morrison
Arthur B. Raitano
Douglas Saffran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agensys Inc
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/001,469 external-priority patent/US7208280B2/en
Priority claimed from US10/017,066 external-priority patent/US6838258B2/en
Application filed by Agensys Inc filed Critical Agensys Inc
Publication of AU2002309873A1 publication Critical patent/AU2002309873A1/en
Application granted granted Critical
Publication of AU2002309873B2 publication Critical patent/AU2002309873B2/en
Priority to AU2008200363A priority Critical patent/AU2008200363B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002309873A 2001-05-15 2002-05-15 Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer Ceased AU2002309873B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008200363A AU2008200363B2 (en) 2001-05-15 2008-01-18 Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US29111801P 2001-05-15 2001-05-15
US60/291,118 2001-05-15
US10/001,469 US7208280B2 (en) 1999-10-05 2001-10-31 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
US10/001,469 2001-10-31
US10/017,066 2001-12-14
US10/017,066 US6838258B2 (en) 1999-10-05 2001-12-14 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
PCT/US2002/015520 WO2002092842A2 (en) 2001-05-15 2002-05-15 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008200363A Division AU2008200363B2 (en) 2001-05-15 2008-01-18 Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer

Publications (2)

Publication Number Publication Date
AU2002309873A1 AU2002309873A1 (en) 2003-05-01
AU2002309873B2 true AU2002309873B2 (en) 2007-10-18

Family

ID=38616826

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002309873A Ceased AU2002309873B2 (en) 2001-05-15 2002-05-15 Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer
AU2008200363A Ceased AU2008200363B2 (en) 2001-05-15 2008-01-18 Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2008200363A Ceased AU2008200363B2 (en) 2001-05-15 2008-01-18 Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer

Country Status (6)

Country Link
EP (1) EP1539805A4 (enExample)
JP (1) JP2005512509A (enExample)
AU (2) AU2002309873B2 (enExample)
CA (1) CA2447564A1 (enExample)
IL (1) IL158860A0 (enExample)
WO (1) WO2002092842A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
US7208280B2 (en) 1999-10-05 2007-04-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
CA2517287C (en) * 2003-02-28 2022-12-13 The Johns Hopkins University Regulation of t cells by lag-3 (cd223)
JP5122592B2 (ja) * 2010-01-04 2013-01-16 アジェンシス，インコーポレイテッド 癌の処置および検出において有用な２４ｐ４ｃ１２と称される、核酸および対応タンパク質
US10722563B2 (en) * 2012-09-20 2020-07-28 Shenzhen Innovation Immunotechnology Co., Ltd. Prostate-specific tumor antigens and uses thereof
CN111549140B (zh) * 2020-06-08 2023-08-08 重庆医科大学附属第一医院 一种检测肺癌相关基因C2orf40、FIBIN和GRP甲基化的试剂盒及其应用
CN119920083B (zh) * 2025-01-21 2025-10-31 重庆邮电大学 一种通信中断条件下基于事件触发的混行车群切换协同控制方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914142B9 (en) * 1996-03-11 2012-01-04 Epimmune Inc. Peptides with increased binding affinity for at least three hla-a3-like molecules
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2000044775A2 (en) * 1999-01-27 2000-08-03 Epimmune Inc. Identification of broadly reactive hla restricted t cell epitopes
US7361338B2 (en) * 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
ATE524549T1 (de) * 1999-10-05 2011-09-15 Agensys Inc G protein-gekoppelter in prostatakrebs hochexprimierter rezeptor und seine verwendungen
AU2903701A (en) * 1999-10-08 2001-04-23 Digiscents Olfactory receptor sequences
US20030088059A1 (en) * 2000-03-13 2003-05-08 Sergey Zozulya Human olfactory receptors and genes encoding same
AU2001249549A1 (en) * 2000-03-27 2001-10-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2001074904A2 (en) * 2000-03-31 2001-10-11 Curagen Corporation G-protein coupled receptors and nucleic acids encoding same
US20030022237A1 (en) * 2000-09-27 2003-01-30 Feder John N. Novel human G-protein coupled receptor, HGPRBMY4, expressed highly in prostate, colon, and lung
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
US20030108963A1 (en) * 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins

Also Published As

Publication number Publication date
AU2008200363A8 (en) 2008-03-13
AU2008200363B2 (en) 2010-08-12
WO2002092842A3 (en) 2005-04-21
EP1539805A2 (en) 2005-06-15
EP1539805A4 (en) 2005-11-16
AU2008200363A1 (en) 2008-02-21
IL158860A0 (en) 2004-05-12
JP2005512509A (ja) 2005-05-12
WO2002092842A2 (en) 2002-11-21
CA2447564A1 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
US7795391B2 (en) Protein showing enhanced expression in cancer cells
US7759474B2 (en) Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
WO2004016733A2 (en) Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
US8003100B2 (en) Antibodies that bind to 238P1B2
US7982004B2 (en) Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
AU2008200363B2 (en) Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer
US8039603B2 (en) Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US8173381B2 (en) Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer
US20100086985A1 (en) Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer
AU2002309873A1 (en) Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer
US7208280B2 (en) Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
US8647826B2 (en) Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
US20030134784A1 (en) Nucleic acids and corresponding proteins entitled 83P2H3 and CaTrF2E11 useful in treatment and detection of cancer
US20120076789A1 (en) Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
IL158860A (en) 101p3a11 peptides for use in vaccine preparation

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE PRIORITY DETAILS FROM 10/017,666 14 DEC 2001 US TO 10/017,066 14 DEC 2001 US

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired